| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,734 | 16,702 | 16,722 | 14,876 | | Cost of Revenue | 14,488 | 14,848 | 15,039 | 14,870 | | | Gross Profit | 1,246 | 1,854 | 1,683 | 6 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,644 | 2,220 | 2,340 | 2,901 | | Non Recurring |
-
|
-
|
-
| 4,747 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (398) | (366) | (657) | (7,642) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 147 | (5,561) | 1,974 |
-
| | Earnings Before Interest And Taxes | (251) | (5,927) | 1,317 | (7,642) | | Interest Expense | 1,535 | 1,456 | 1,333 | 372 | | Income Before Tax | (1,786) | (7,383) | (16) | (8,014) | | Income Tax Expense | 23 |
-
| 5 | (4) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,809) | (7,383) | (21) | (8,010) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (573) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,809) | (7,383) | (21) | (8,583) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,809) | ($7,383) | ($21) | ($8,583) |
|
0.64% Nasdaq 
0.01 (2.27%) 
Income Statement
